PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis

M Waldman, V Nudelman, A Shainberg… - Experimental cell …, 2018 - Elsevier
Abstract Type 2 diabetes mellitus (DM2) follows impaired glucose tolerance in obesity and is
frequently associated with hypertension, causing adverse myocardial remodelling and …
被引用次数：68 相关文章

PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis

M Waldman, V Nudelman… - Experimental cell …, 2018 - pubmed.ncbi.nlm.nih.gov
Type 2 diabetes mellitus (DM2) follows impaired glucose tolerance in obesity and is
frequently associated with hypertension, causing adverse myocardial remodelling and …

PARP-1 Inhibition Protects the Diabetic Heart Through Activation of SIRT1-PGC-1alpha Axis

M Waldman, V Nudelman… - Experimental Cell …, 2018 - touroscholar.touro.edu
Abstract Type 2 diabetes mellitus (DM2) follows impaired glucose tolerance in obesity and is
frequently associated with hypertension, causing adverse myocardial remodelling and …

PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis

M Waldman, V Nudelman, A Shainberg… - Experimental Cell …, 2018 - osti.gov
Type 2 diabetes mellitus (DM2) follows impaired glucose tolerance in obesity and is
frequently associated with hypertension, causing adverse myocardial remodelling and …

[引用][C] PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis

M Waldman, V Nudelman, A Shainberg… - Experimental Cell …, 2018 - cir.nii.ac.jp
PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis

M Waldman, V Nudelman, A Shainberg… - Experimental Cell …, 2018 - inis.iaea.org
[en] Type 2 diabetes mellitus (DM2) follows impaired glucose tolerance in obesity and is
frequently associated with hypertension, causing adverse myocardial remodelling and …

PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis.

M Waldman, V Nudelman, A Shainberg… - Experimental Cell …, 2018 - europepmc.org
Methods Obese Leptin resistant (db/db) mice suffering from DM2, were treated with
angiotensin II (AT) for 4 weeks to enhance the development of cardiomyopathy. Mice were …